#
Jivi recombinant
  • Treatments
  • Hemophilia A

Jivi (recombinant)

Generic name:antihemophilic factor (recombinant)ant-ee-hee-moe-FIL-ik-FAK-tor ]
Brand names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Esperoct, ... show all 14 brands
Drug class:Miscellaneous coagulation modifiers

Medically reviewed by Drugs.com on Apr 6, 2022. Written by Cerner Multum.

What is recombinant Jivi?

Jivi (clotting factor) is a naturally occurring protein in the blood. People with hemophilia A have a deficiency in clotting factor VIII. Recombinant this medicine replaces clotting factor VIII in the blood.

Recombinant Jivi is used to treat or prevent bleeding episodes in adults and children with hemophilia A. Jivi is sometimes given before a surgery.

Recombinant Jivi can help prevent joint damage in children who have hemophilia A and no prior joint damage.

Recombinant Jivi is not for use in treating von Willebrand disease.

Jivi is not approved for use by anyone younger than 12 years old.

Recombinant Jivi may also be used for purposes not listed in this medication guide.

Warnings

Carefully follow all instructions about how to mix and store this medicine. Different brands of recombinant Jivi may have different storage instructions.

Your body may develop antibodies to Jivi, making it less effective. Call your doctor if this medicine seems to be less effective in controlling your bleeding.

Before ta